CONSUN PHARMAC.GR.HD -10 (C1P) — Cash Flow Quality Index
CONSUN PHARMAC.GR.HD -10 (C1P) has a Cash Flow Quality Index of 1.12x as of December 2025. Operating cash flow of €1.21 Billion exceeds net income of €1.08 Billion, indicating high earnings quality where cash backs reported profits. Explore C1P cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CONSUN PHARMAC.GR.HD -10 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for CONSUN PHARMAC.GR.HD -10 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check CONSUN PHARMAC.GR.HD -10 (C1P) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for CONSUN PHARMAC.GR.HD -10 (2021–2025)
Year-by-year earnings quality comparison for CONSUN PHARMAC.GR.HD -10. For live market cap and the full company financial profile, see CONSUN PHARMAC.GR.HD -10 (C1P) market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.12x | €1.21 Billion | €1.08 Billion | ▼ -5.9% |
| 2024 | 1.19x | €1.09 Billion | €910.46 Million | ▲ +14.4% |
| 2023 | 1.04x | €818.97 Million | €784.53 Million | ▼ -24.8% |
| 2022 | 1.39x | €947.68 Million | €682.91 Million | ▲ +12.9% |
| 2021 | 1.23x | €725.54 Million | €590.17 Million | — |